Pulmonx (LUNG) News Today $7.75 -0.09 (-1.15%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 10:19 AM | finance.yahoo.comPulmonx Corporation (LUNG)July 24 at 6:12 AM | marketbeat.comPulmonx (LUNG) Scheduled to Post Earnings on WednesdayPulmonx (NASDAQ:LUNG) will be releasing earnings after the market closes on Wednesday, July 31, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=465680)July 24 at 3:17 AM | americanbankingnews.comPulmonx Co. (NASDAQ:LUNG) Receives $15.71 Consensus Price Target from AnalystsJuly 21, 2024 | seekingalpha.comPulmonx: Low Bar For Q2 EarningsJuly 21, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesPulmonx Co. (NASDAQ:LUNG - Get Free Report) has been given an average recommendation of "Moderate Buy" by the seven research firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the comJuly 14, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Short Interest Down 14.3% in JunePulmonx Co. (NASDAQ:LUNG - Get Free Report) was the recipient of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 1,200,000 shares, a drop of 14.3% from the June 15th total of 1,400,000 shares. Approximately 3.4% of the shares of the company are short sold. Based on an average trading volume of 436,600 shares, the days-to-cover ratio is presently 2.7 days.July 10, 2024 | globenewswire.comPulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024June 26, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Receives Consensus Rating of "Moderate Buy" from BrokeragesPulmonx Co. (NASDAQ:LUNG - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the seven research firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and six have given a buy recommendatJune 12, 2024 | marketbeat.comBraidwell LP Sells 200,605 Shares of Pulmonx Co. (NASDAQ:LUNG)Braidwell LP reduced its stake in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 20.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 787,954 shares of the company's stock after selling 200,605 shares during the period. Braidwell LP owned approximatelyJune 6, 2024 | insidertrades.comPulmonx Co. (NASDAQ:LUNG) Insider Geoffrey Beran Rose Sells 4,297 SharesJune 6, 2024 | insidertrades.comInsider Selling: Pulmonx Co. (NASDAQ:LUNG) General Counsel Sells 5,475 Shares of StockJune 4, 2024 | marketbeat.comPulmonx (NASDAQ:LUNG) Coverage Initiated at Lake Street CapitalLake Street Capital began coverage on shares of Pulmonx in a research report on Tuesday. They issued a "buy" rating and a $12.00 target price for the company.June 3, 2024 | marketbeat.comPura Vida Investments LLC Has $6.09 Million Position in Pulmonx Co. (NASDAQ:LUNG)Pura Vida Investments LLC reduced its holdings in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 34.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 477,398 shares of the company's stock after sellingMay 25, 2024 | marketbeat.comPrimecap Management Co. CA Has $71.99 Million Holdings in Pulmonx Co. (NASDAQ:LUNG)Primecap Management Co. CA grew its position in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 2.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,646,451 shares of the company's stock after buying anMay 24, 2024 | insidertrades.comPulmonx Co. (NASDAQ:LUNG) Insider Sells $10,312.64 in StockMay 23, 2024 | marketbeat.comInsider Selling: Pulmonx Co. (NASDAQ:LUNG) Insider Sells 1,184 Shares of StockPulmonx Co. (NASDAQ:LUNG - Get Free Report) insider Geoffrey Beran Rose sold 1,184 shares of the firm's stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $8.71, for a total value of $10,312.64. Following the sale, the insider now directly owns 305,500 shares of the company's stock, valued at approximately $2,660,905. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.May 13, 2024 | marketbeat.comVictory Capital Management Inc. Lowers Stock Position in Pulmonx Co. (NASDAQ:LUNG)Victory Capital Management Inc. decreased its position in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 10.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 853,846 shares of the company's stock after selling 96,917 shares during theMay 6, 2024 | globenewswire.comPulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)May 4, 2024 | finance.yahoo.comEarnings Update: Pulmonx Corporation (NASDAQ:LUNG) Just Reported Its First-Quarter Results And Analysts Are Updating Their ForecastsMay 3, 2024 | finance.yahoo.comPulmonx First Quarter 2024 Earnings: Beats ExpectationsMay 3, 2024 | finance.yahoo.comPulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call TranscriptMay 2, 2024 | marketbeat.comPulmonx (NASDAQ:LUNG) PT Lowered to $15.00 at Canaccord Genuity GroupCanaccord Genuity Group cut their target price on shares of Pulmonx from $16.00 to $15.00 and set a "buy" rating for the company in a research report on Thursday.May 2, 2024 | markets.businessinsider.comAnalyst Recommendation Report Summary: Insights and Strategic Investment PerspectivesMay 2, 2024 | marketwatch.comPulmonx Surge After Strong 1Q PerformanceMay 2, 2024 | marketbeat.comPulmonx (NASDAQ:LUNG) Announces Quarterly Earnings ResultsPulmonx (NASDAQ:LUNG - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.36) EPS for the quarter, topping the consensus estimate of ($0.43) by $0.07. The firm had revenue of $18.85 million for the quarter, compared to analysts' expectations of $17.54 million. Pulmonx had a negative return on equity of 46.63% and a negative net margin of 88.60%. During the same quarter in the previous year, the company earned ($0.42) earnings per share.May 2, 2024 | finance.yahoo.comQ1 2024 Pulmonx Corp Earnings CallMay 2, 2024 | finance.yahoo.comPulmonx Corp (LUNG) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ...May 1, 2024 | investorplace.comLUNG Stock Earnings: Pulmonx Beats EPS, Beats Revenue for Q1 2024May 1, 2024 | finance.yahoo.comPulmonx Corp (LUNG) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Continued LossesMay 1, 2024 | globenewswire.comPulmonx Reports First Quarter 2024 Financial ResultsApril 25, 2024 | finance.yahoo.comPulmonx Corporation (LUNG) Stock Price, News, Quote & History - Yahoo FinanceApril 10, 2024 | globenewswire.comPulmonx to Report First Quarter 2024 Financial Results on May 1, 2024April 4, 2024 | investing.comPulmonx names new CFO to bolster financial leadershipApril 3, 2024 | markets.businessinsider.comNavigating 6 Analyst Ratings For PulmonxApril 3, 2024 | marketbeat.comPiper Sandler Reaffirms "Overweight" Rating for Pulmonx (NASDAQ:LUNG)Piper Sandler reaffirmed an "overweight" rating and issued a $17.00 target price on shares of Pulmonx in a report on Wednesday.April 2, 2024 | marketwatch.comPulmonx Taps Mehul Joshi as Finance ChiefApril 2, 2024 | globenewswire.comPulmonx Announces Appointment of Mehul Joshi as Chief Financial OfficerMarch 30, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Short Interest UpdatePulmonx Co. (NASDAQ:LUNG - Get Free Report) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 1,040,000 shares, a drop of 17.5% from the February 29th total of 1,260,000 shares. Currently, 3.0% of the company's stock are short sold. Based on an average daily trading volume, of 458,900 shares, the short-interest ratio is presently 2.3 days.March 26, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Insider Sells $11,082.24 in StockPulmonx Co. (NASDAQ:LUNG - Get Free Report) insider Geoffrey Beran Rose sold 1,184 shares of the stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of $9.36, for a total value of $11,082.24. Following the completion of the sale, the insider now directly owns 307,868 shares of the company's stock, valued at $2,881,644.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.March 17, 2024 | ca.finance.yahoo.comLUNG Apr 2024 12.500 callMarch 16, 2024 | finanznachrichten.dePulmonx Corporation: Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)March 16, 2024 | marketbeat.comWalleye Capital LLC Takes Position in Pulmonx Co. (NASDAQ:LUNG)Walleye Capital LLC acquired a new stake in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 372,290 shares of the company's stock, valued at approximately $3,846,000.March 15, 2024 | globenewswire.comPulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)March 14, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Sells 175,166 Shares of Pulmonx Co. (NASDAQ:LUNG)Jacobs Levy Equity Management Inc. cut its stake in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 25.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 505,379 shares of the companMarch 7, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Shares Sold by Deutsche Bank AGDeutsche Bank AG decreased its holdings in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 91.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 46,868 shares of the company's stock after selling 490,932 shares during tMarch 5, 2024 | marketbeat.comFmr LLC Has $20.97 Million Stake in Pulmonx Co. (NASDAQ:LUNG)Fmr LLC lifted its position in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 24.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 2,029,835 shares of the company's stock after acquiring an additional 401,830 shares during the quarter. Fmr LLC owned aMarch 4, 2024 | ca.finance.yahoo.comLUNG Apr 2024 7.500 putMarch 4, 2024 | ca.finance.yahoo.comLUNG May 2024 7.500 putMarch 3, 2024 | finance.yahoo.comLUNG Aug 2024 10.000 putMarch 3, 2024 | finance.yahoo.comLUNG Apr 2024 10.000 call Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Rare signal predicts 50% market drop - before election (Ad)The market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED will cut rates any day now. But there's one indicator that's flashing a BIG warning sign to investors. Take these 4 steps to protect your retirement here. LUNG Media Mentions By Week LUNG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUNG News Sentiment▼0.280.61▲Average Medical News Sentiment LUNG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUNG Articles This Week▼62▲LUNG Articles Average Week Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Inovio Pharmaceuticals News Today Cerus News Today Atrion News Today Artivion News Today Silk Road Medical News Today BioLife Solutions News Today Avanos Medical News Today National Vision News Today Pulse Biosciences News Today Perspective Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUNG) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmonx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulmonx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.